ImmunoGen, Inc. Annual Operating Income (Loss) in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
ImmunoGen, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
  • ImmunoGen, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was $26M.
  • ImmunoGen, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$80.2M, a 59.1% increase year-over-year.
  • ImmunoGen, Inc. annual Operating Income (Loss) for 2022 was -$221M, a 76.6% decline from 2021.
  • ImmunoGen, Inc. annual Operating Income (Loss) for 2021 was -$125M, a 459% decline from 2020.
  • ImmunoGen, Inc. annual Operating Income (Loss) for 2020 was -$22.4M, a 75.7% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$221M -$95.8M -76.6% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 -$125M -$103M -459% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 -$22.4M +$69.8M +75.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$92.2M +$69.3M +42.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$161M -$102M -174% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$59M +$76.7M +56.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-11
2016 -$136M -$81.2M -149% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$54.5M +$17.1M +23.9% Jul 1, 2014 Jun 30, 2015 10-K 2018-03-07
2014 -$71.5M +$1.48M +2.02% Jul 1, 2013 Jun 30, 2014 10-KT 2017-03-03
2013 -$73M +$248K +0.34% Jul 1, 2012 Jun 30, 2013 10-K 2015-08-27
2012 -$73.3M -$13.1M -21.7% Jul 1, 2011 Jun 30, 2012 10-K 2014-08-28
2011 -$60.2M -$8.95M -17.5% Jul 1, 2010 Jun 30, 2011 10-K 2013-08-29
2010 -$51.2M Jul 1, 2009 Jun 30, 2010 10-K 2012-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.